Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than widely used GLP-1 drugs in older adults with obesity and diabetes, according to a new real-world ...
May 6, 2026
0
6
Drugs commonly used for weight loss, known as GLP-1 receptor agonists, have been found to reduce the key symptoms of binge eating disorder in a new review of evidence led by University College London (UCL) researchers.
Jul 15, 2026
0
6
Type 2 diabetes is often triggered by a sedentary lifestyle or poor diet. At the same time, however, some people have genes that make it much more likely they will develop the disease. In other words, they are far more susceptible ...
Mar 24, 2026
0
6
Nearly 1 in 5 teens in the United States is obese, putting their long-term health at serious risk. Obesity in adolescence leads to many deleterious medical conditions including diabetes, high blood pressure, sleep apnea, ...
Mar 16, 2026
0
6
A new study shows that migration from Mexico to the United States can influence cardiovascular risk profiles. The study's findings are important for clinicians who serve immigrant populations and who would need to consider ...
Apr 2, 2026
0
6
The roots of childhood obesity may begin in the womb. New research led by the George Mason University College of Public Health found that children whose mothers entered pregnancy with obesity were 64% more likely to become ...
Jun 23, 2026
0
6
A pooled analysis of two randomized trials found that decreasing sleep by just 1.5 hours each night was associated with increases in body weight, waist circumference and sedentary time in adults with elevated cardiometabolic ...
Jul 6, 2026
0
6
Losing weight is hard. Keeping it off is often even harder.
Jun 2, 2026
0
6
Metabolic dysfunction, rather than steatotic liver disease (SLD), seems to be the main driver of chronic kidney disease (CKD) risk, according to research published online Feb. 23 in Nutrition & Diabetes.
Feb 27, 2026
0
6
The rapid rise of GLP-1 medications such as semaglutide and tirzepatide has transformed obesity treatment. Still, experts say medications alone are not enough to address one of the nation's most pressing chronic diseases.
Jun 17, 2026
0
6
